Description

3,4,7,8-Tetrahydro-7,7-Dimethyl-2H-Cyclopenta[4,5]Pyrrolo[1,2-A]Pyrazin-1(6H)-One is a high-purity, advanced pharmaceutical intermediate characterized by its complex fused heterocyclic structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug candidates, particularly in central nervous system (CNS) and oncology research.
• Organic Synthesis Building Block: Used in medicinal chemistry for constructing novel molecular scaffolds with potential biological activity.
• Research & Development (R&D): Essential for academic and industrial laboratories exploring new chemical entities and structure-activity relationships (SAR).
• Process Chemistry: Serves as a starting material or intermediate in scale-up and optimization studies for API manufacturing processes.
• Contract Manufacturing Organizations (CMOs): Supplied to CMOs producing custom APIs and advanced intermediates for client pipelines.

Basic Information

Product Name	3,4,7,8-Tetrahydro-7,7-Dimethyl-2H-Cyclopenta[4,5]Pyrrolo[1,2-A]Pyrazin-1(6H)-One
CAS No.	1346674-23-4
Molecular Formula	C12H16N2O
Molecular Weight	204.27 g/mol
Synonyms	7,7-Dimethyl-1,2,3,4,6,7,8,8a-octahydrocyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one; Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one, 3,4,7,8-tetrahydro-7,7-dimethyl-; CAS 1346674-23-4; Fused tricyclic pyrrolopyrazinone derivative; Advanced pharmaceutical intermediate 1346674-23-4
EINECS	Contact for details

Quality Control

Our production of 3,4,7,8-Tetrahydro-7,7-Dimethyl-2H-Cyclopenta[4,5]Pyrrolo[1,2-A]Pyrazin-1(6H)-One adheres to stringent quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and manufacturing. Certificates of Analysis (COA) detailing all specifications are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.